Clinical Trials Logo
  1. Home
  2. Other
  3. NCT06356194

Drug-drug Interaction Study of Biktarvy and Bemnifosbuvir/Ruzasvir

Healthy Volunteer Study Clinical Trial

Official title:
A Phase 1, Open-Label, Multiple Dose Study to Evaluate the Drug-Drug Interaction Potential Between Bemnifosbuvir/Ruzasvir and Bictegravir/Emtricitabine/Tenofovir Alafenamide (Biktarvy®) in Healthy Adult Subjects

Clinical Trial Summary

Drug-drug interaction study of Biktarvy and Bemnifosbuvir/Ruzasvir

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT06356194
Study type Interventional
Source Atea Pharmaceuticals, Inc.
Contact Atea Study Clinical Trials Administrator
Phone 888-481-1607
Email ateaclinicaltrials@ateapharma.com
Status Not yet recruiting
Phase Phase 1
Start date April 15, 2024
Completion date May 30, 2024
View Details
See also
  Status Clinical Trial Phase
Completed NCT03270878 - Glasdegib Absolute Bioavailability Study Phase 1
Completed NCT03777488 - Pharmacokinetics of Tranexamic Acid After Oral, Intramuscular or Intravenous Administration: a Prospective, Randomised, Cross-over Trial in Healthy Volunteers. Phase 1
Completed NCT03086278 - A Study of AST-008 in Healthy Subjects Phase 1
Completed NCT04711187 - Study of AT-527 in Healthy Subjects (R07496998) Phase 1
Completed NCT06141889 - Pharmacokinetics Study of Azelaprag (BGE-105) in Older Adult Healthy Volunteers Phase 1
Completed NCT05154123 - Drug-drug Interaction Study of Rosuvastatin and AT-527 (R07496998) Phase 1
Completed NCT05179421 - Dose Ranging Study of Intravenous Oxytocin for Analgesia to Heat Pain Phase 2
Completed NCT03945344 - Effect of Charcoal on Gastrointestinal Absorption of Tiotropium Phase 1
Recruiting NCT05881993 - Study of CBP-4888 in Healthy, Non-Pregnant Female Subjects Early Phase 1
Completed NCT04242953 - Study to Determine Safety, Tolerability and Pharmacokinetics, of SCO-120 in Healthy Male and Post-menopausal Female Subjects Phase 1
Completed NCT02393950 - Safety, Tolerability,Pharmacokinetics and Pharmacodynamics of ODM-106 in Healthy Volunteers Phase 1
Completed NCT00866385 - AZD8566 Food Effect/Microtracer Study Phase 1
Completed NCT04784000 - Effect of Carbamazepine on the Pharmacokinetics (PK) of AT-527 Phase 1
Completed NCT01609218 - A Study of LY2140023 in Healthy Participants Phase 1
Completed NCT02503085 - Ibuprofen Suspension Bioequivalence Study Phase 1
Completed NCT05004415 - Mass Balance Study of AT-527 in Healthy Adult Male Subjects (R07496998) Phase 1
Completed NCT02256423 - A Study Comparing Three Formulations of Ibuprofen in Healthy Subjects Phase 1
Completed NCT01425450 - Safety Study of Four Doses of the Study Drug, HF1020 in Healthy Volunteers Phase 1
Completed NCT05731843 - Drug-drug Interaction Study of Ruzasvir and Bemnifosbuvir Phase 1
Completed NCT03031535 - Study of Intranasal Octreotide (DP1038) in Healthy Adult Volunteers Phase 1